In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts

Muhammad Shafiq; Lina Wang; Dengke Zhi; Qiuying Zhang; Kai Wang; Lianyong Wang; Dong Hwee Kim; Deling Kong; Soo Hyun Kim

doi:10.1002/jbm.b.34260

In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts

Muhammad Shafiq, Lina Wang, Dengke Zhi, Qiuying Zhang, Kai Wang, Lianyong Wang, Dong Hwee Kim, Deling Kong, Soo Hyun Kim

KU-KIST Graduate School of Converging Science and Technology

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

In situ blood vessel regeneration through host stem/progenitor cell mobilization may hold great promise for vascular reconstruction. Neuropeptide substance P (SP) has been shown to accelerate tissue repair by endogenous cell mobilization and recruitment. This study was aimed to evaluate the vascular regeneration potential of SP and heparin co-tethered vascular grafts. Polycaprolactone (PCL), PCL/SP-conjugated poly(L-lactide-co-ε-caprolactone) (PLCL-SP) (SP), and PCL/PLCL-SP/heparin-conjugated PLCL (Hep/SP) vascular grafts were implanted as rat abdominal aorta substitutes for up to 2 weeks and 4 weeks. Ex vivo results delineate that heparin can improve the hemocompatibility and SP can recruit mesenchymal stem cells. Histological and immunohistochemical staining reveal higher cellular infiltration and homogeneous cell distribution in SP and Hep/SP grafts than that of the control grafts. At 4 weeks, SP and Hep/SP grafts show the presence of cobblestone-like cells on the luminal side, whereas the surface of PCL grafts remains bare. Immunoflourescence staining using von Willibrand factor (vWF) antibody shows improved endothelialization in SP and Hep/SP grafts compared with the PCL grafts. SP and Hep/SP grafts also exhibit more numbers of α-smooth muscle actin-positive cells and laminin⁺ blood vessels than that of the control group. Evaluation of inflammatory response reveals that three groups did not differ in terms of the numbers of CD68⁺ macrophages, whereas SP and Hep/SP grafts show higher numbers of CD206⁺ macrophages. These results indicate that SP can induce endogenous tissue regeneration in cell-free grafts, which may be of great interest for regenerative medicine and tissue engineering applications.

Original language	English
Pages (from-to)	1669-1683
Number of pages	15
Journal	Journal of Biomedical Materials Research - Part B Applied Biomaterials
Volume	107
Issue number	5
DOIs	https://doi.org/10.1002/jbm.b.34260
Publication status	Published - 2019 Jul

Bibliographical note

Funding Information:
Additional Supporting Information may be found in the online version of this article. †These authors contributed equally to this work. Correspondence to: S. H. Kim; e-mail: soohkim@kist.re.kr and L. Wang; e-mail: wly@nankai.edu.cn Contract grant sponsor: KIST Institutional Program and KU-KIST Graduate School of Converging Science and Technology Program Contract grant sponsor: KU-KIST Graduate School Contract grant sponsor: KIST Contract grant sponsor: National Nature Science Foundation of China; contract grant number: 31670990, 81530059, 81772000

Funding Information:
This work was supported by the National Nature Science Foundation of China (Grant number 31670990, 81530059, 81772000), KIST Institutional Program, and by the KU-KIST Graduate School of Converging Science and Technology Program.

Publisher Copyright:
© 2018 Wiley Periodicals, Inc.

Keywords

bioactive material
graft/copolymer
stem cells
tissue engineering
vascular graft

ASJC Scopus subject areas

Biomaterials
Biomedical Engineering

Access to Document

10.1002/jbm.b.34260

Cite this

@article{343a4add3b9b4fc18320608aa6b2a09a,

title = "In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts",

abstract = "In situ blood vessel regeneration through host stem/progenitor cell mobilization may hold great promise for vascular reconstruction. Neuropeptide substance P (SP) has been shown to accelerate tissue repair by endogenous cell mobilization and recruitment. This study was aimed to evaluate the vascular regeneration potential of SP and heparin co-tethered vascular grafts. Polycaprolactone (PCL), PCL/SP-conjugated poly(L-lactide-co-ε-caprolactone) (PLCL-SP) (SP), and PCL/PLCL-SP/heparin-conjugated PLCL (Hep/SP) vascular grafts were implanted as rat abdominal aorta substitutes for up to 2 weeks and 4 weeks. Ex vivo results delineate that heparin can improve the hemocompatibility and SP can recruit mesenchymal stem cells. Histological and immunohistochemical staining reveal higher cellular infiltration and homogeneous cell distribution in SP and Hep/SP grafts than that of the control grafts. At 4 weeks, SP and Hep/SP grafts show the presence of cobblestone-like cells on the luminal side, whereas the surface of PCL grafts remains bare. Immunoflourescence staining using von Willibrand factor (vWF) antibody shows improved endothelialization in SP and Hep/SP grafts compared with the PCL grafts. SP and Hep/SP grafts also exhibit more numbers of α-smooth muscle actin-positive cells and laminin+ blood vessels than that of the control group. Evaluation of inflammatory response reveals that three groups did not differ in terms of the numbers of CD68+ macrophages, whereas SP and Hep/SP grafts show higher numbers of CD206+ macrophages. These results indicate that SP can induce endogenous tissue regeneration in cell-free grafts, which may be of great interest for regenerative medicine and tissue engineering applications.",

keywords = "bioactive material, graft/copolymer, stem cells, tissue engineering, vascular graft",

author = "Muhammad Shafiq and Lina Wang and Dengke Zhi and Qiuying Zhang and Kai Wang and Lianyong Wang and Kim, {Dong Hwee} and Deling Kong and Kim, {Soo Hyun}",

note = "Funding Information: Additional Supporting Information may be found in the online version of this article. †These authors contributed equally to this work. Correspondence to: S. H. Kim; e-mail: soohkim@kist.re.kr and L. Wang; e-mail: wly@nankai.edu.cn Contract grant sponsor: KIST Institutional Program and KU-KIST Graduate School of Converging Science and Technology Program Contract grant sponsor: KU-KIST Graduate School Contract grant sponsor: KIST Contract grant sponsor: National Nature Science Foundation of China; contract grant number: 31670990, 81530059, 81772000 Funding Information: This work was supported by the National Nature Science Foundation of China (Grant number 31670990, 81530059, 81772000), KIST Institutional Program, and by the KU-KIST Graduate School of Converging Science and Technology Program. Publisher Copyright: {\textcopyright} 2018 Wiley Periodicals, Inc.",

year = "2019",

month = jul,

doi = "10.1002/jbm.b.34260",

language = "English",

volume = "107",

pages = "1669--1683",

journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",

issn = "1552-4973",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts

AU - Shafiq, Muhammad

AU - Wang, Lina

AU - Zhi, Dengke

AU - Zhang, Qiuying

AU - Wang, Kai

AU - Wang, Lianyong

AU - Kim, Dong Hwee

AU - Kong, Deling

AU - Kim, Soo Hyun

N1 - Funding Information: Additional Supporting Information may be found in the online version of this article. †These authors contributed equally to this work. Correspondence to: S. H. Kim; e-mail: soohkim@kist.re.kr and L. Wang; e-mail: wly@nankai.edu.cn Contract grant sponsor: KIST Institutional Program and KU-KIST Graduate School of Converging Science and Technology Program Contract grant sponsor: KU-KIST Graduate School Contract grant sponsor: KIST Contract grant sponsor: National Nature Science Foundation of China; contract grant number: 31670990, 81530059, 81772000 Funding Information: This work was supported by the National Nature Science Foundation of China (Grant number 31670990, 81530059, 81772000), KIST Institutional Program, and by the KU-KIST Graduate School of Converging Science and Technology Program. Publisher Copyright: © 2018 Wiley Periodicals, Inc.

PY - 2019/7

Y1 - 2019/7

N2 - In situ blood vessel regeneration through host stem/progenitor cell mobilization may hold great promise for vascular reconstruction. Neuropeptide substance P (SP) has been shown to accelerate tissue repair by endogenous cell mobilization and recruitment. This study was aimed to evaluate the vascular regeneration potential of SP and heparin co-tethered vascular grafts. Polycaprolactone (PCL), PCL/SP-conjugated poly(L-lactide-co-ε-caprolactone) (PLCL-SP) (SP), and PCL/PLCL-SP/heparin-conjugated PLCL (Hep/SP) vascular grafts were implanted as rat abdominal aorta substitutes for up to 2 weeks and 4 weeks. Ex vivo results delineate that heparin can improve the hemocompatibility and SP can recruit mesenchymal stem cells. Histological and immunohistochemical staining reveal higher cellular infiltration and homogeneous cell distribution in SP and Hep/SP grafts than that of the control grafts. At 4 weeks, SP and Hep/SP grafts show the presence of cobblestone-like cells on the luminal side, whereas the surface of PCL grafts remains bare. Immunoflourescence staining using von Willibrand factor (vWF) antibody shows improved endothelialization in SP and Hep/SP grafts compared with the PCL grafts. SP and Hep/SP grafts also exhibit more numbers of α-smooth muscle actin-positive cells and laminin+ blood vessels than that of the control group. Evaluation of inflammatory response reveals that three groups did not differ in terms of the numbers of CD68+ macrophages, whereas SP and Hep/SP grafts show higher numbers of CD206+ macrophages. These results indicate that SP can induce endogenous tissue regeneration in cell-free grafts, which may be of great interest for regenerative medicine and tissue engineering applications.

AB - In situ blood vessel regeneration through host stem/progenitor cell mobilization may hold great promise for vascular reconstruction. Neuropeptide substance P (SP) has been shown to accelerate tissue repair by endogenous cell mobilization and recruitment. This study was aimed to evaluate the vascular regeneration potential of SP and heparin co-tethered vascular grafts. Polycaprolactone (PCL), PCL/SP-conjugated poly(L-lactide-co-ε-caprolactone) (PLCL-SP) (SP), and PCL/PLCL-SP/heparin-conjugated PLCL (Hep/SP) vascular grafts were implanted as rat abdominal aorta substitutes for up to 2 weeks and 4 weeks. Ex vivo results delineate that heparin can improve the hemocompatibility and SP can recruit mesenchymal stem cells. Histological and immunohistochemical staining reveal higher cellular infiltration and homogeneous cell distribution in SP and Hep/SP grafts than that of the control grafts. At 4 weeks, SP and Hep/SP grafts show the presence of cobblestone-like cells on the luminal side, whereas the surface of PCL grafts remains bare. Immunoflourescence staining using von Willibrand factor (vWF) antibody shows improved endothelialization in SP and Hep/SP grafts compared with the PCL grafts. SP and Hep/SP grafts also exhibit more numbers of α-smooth muscle actin-positive cells and laminin+ blood vessels than that of the control group. Evaluation of inflammatory response reveals that three groups did not differ in terms of the numbers of CD68+ macrophages, whereas SP and Hep/SP grafts show higher numbers of CD206+ macrophages. These results indicate that SP can induce endogenous tissue regeneration in cell-free grafts, which may be of great interest for regenerative medicine and tissue engineering applications.

KW - bioactive material

KW - graft/copolymer

KW - stem cells

KW - tissue engineering

KW - vascular graft

UR - http://www.scopus.com/inward/record.url?scp=85054792400&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.34260

DO - 10.1002/jbm.b.34260

M3 - Article

C2 - 30315717

AN - SCOPUS:85054792400

SN - 1552-4973

VL - 107

SP - 1669

EP - 1683

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

IS - 5

ER -

In situ blood vessel regeneration using neuropeptide substance P-conjugated small-diameter vascular grafts

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this